Debt-to-equity of Cardio Diagnostics Holdings, Inc. from 30 Sep 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Cardio Diagnostics Holdings, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2022 to 30 Sep 2025.
  • Cardio Diagnostics Holdings, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 8%, a 76% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Cardio Diagnostics Holdings, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 8% -27% -76% 30 Sep 2025
Q2 2025 10% -55% -85% 30 Jun 2025
Q1 2025 13% -79% -86% 31 Mar 2025
Q4 2024 21% -101% -83% 31 Dec 2024
Q3 2024 35% -78% -69% 30 Sep 2024
Q2 2024 65% +8% +14% 30 Jun 2024
Q1 2024 92% +63% +214% 31 Mar 2024
Q4 2023 122% +110% +896% 31 Dec 2023
Q3 2023 113% +108% +2119% 30 Sep 2023
Q2 2023 57% 30 Jun 2023
Q1 2023 29% 31 Mar 2023
Q4 2022 12% 31 Dec 2022
Q3 2022 5% 30 Sep 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.